secwatch.observer — SEC 8-K summary
======================================

Issuer:     QuidelOrtho Corp (QDEL)
CIK:        0001906324
Form:       8-K
Filed at:   2023-11-01T23:59:59+00:00
Accession:  0001906324-23-000056
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QuidelOrtho Q3 revenue $744M, GAAP loss $0.19/sh, adj EPS $0.90; maintains FY guidance
--------------------------------------------------------------------------------

- Total revenue $744.0M, down from $783.8M YoY; respiratory revenue declined 21% as anticipated.
- GAAP net loss $(13)M, diluted loss per share $(0.19); adjusted diluted EPS $0.90 vs $1.85 prior year.
- Non-respiratory revenue grew 2% (constant currency) driven by Labs business strength.
- Adjusted EBITDA $169M with 23% margin; company paid down $52M on term loan in Q3, $175M year-to-date.
- Fiscal 2023 guidance maintained: total revenue $2.88–$3.08B, adjusted EPS $4.85–$5.30.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1906324/000190632423000056/0001906324-23-000056-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1906324/000190632423000056/qdel-20231101.htm
  HTML page:      https://secwatch.observer/filing/0001906324-23-000056

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer